NeuroQore

San Francisco, United States

NeuroQore offers a novel form of rTMS with an enhanced pulse, with personalized targeting, and post-treatment brain assessments.

$1.5M raised

Sep 2025

Undisclosed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NeuroQore raised?

NeuroQore has raised $1.5M in total funding. The most recent round was Undisclosed. The last funding was announced in September 2025.

Who are NeuroQore's investors?

NeuroQore's investors include SOSV, SOSV SF & NY (Fka IndieBio), Ontario Brain Institute.

Where is NeuroQore headquartered?

NeuroQore is headquartered in San Francisco, United States.

What does NeuroQore do?

NeuroQore offers a novel form of rTMS with an enhanced pulse, with personalized targeting, and post-treatment brain assessments.

What stage is NeuroQore at?

NeuroQore is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 26, 2025.

MLA

"NeuroQore — Funding & Investors." VCBacked, September 26, 2025, https://www.vcbacked.co/company/neuroqore. Accessed July 3, 2026.

APA

VCBacked. (2025). NeuroQore — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/neuroqore

Wikipedia (cite web)

{{cite web |title=NeuroQore — Funding & Investors |url=https://www.vcbacked.co/company/neuroqore |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 26, 2025.